To identify new trends and methodological challenges in oncology health economics and outcomes research with the intent of supporting education, awareness, and community engagement while working towards the development of recommendations to address them.
Oncology is one of the most rapidly evolving therapeutic areas with considerable clinical and economic burden. Health economics and outcomes research in oncology is complicated by (1) the diversity of the epidemiology and biology of various tumors, which limits the sample size and long-term follow-up in clinical trials, (2) the rapidly evolving treatment landscapes and variation in national management recommendations, and (3) the complexities of measuring costs and quality of life in patients and caregivers. Therefore, oncology health economics and outcomes research constitutes a unique segment, and our SIG aims to advance clinical and methodological knowledge for proper clinical and economic evaluation of oncology treatments and diagnostic tools.
Engage the oncology community to raise awareness of key components in oncology HEOR and recommended practices.
Offer relevant and impactful educational presentations and activities on the latest oncology HEOR topics.
Create a space to support the discussion of methods of statistical analysis and economic evaluation in oncology, and approaches to support timely access of innovative oncology treatments and diagnostic tools.
Manuscript and Reports
- Schulman KL, Berenson K, Shih Y-C (T), et al. A Checklist for Ascertaining Study Cohorts in Oncology Health Services Research Using Secondary Data: Report of the ISPOR Oncology Good Outcomes Research Practices Working Group. Value in Health. 2013;16(4):655-669
- Evaluating the role of single-arm trials in oncology decision-making: an interview with Sorrel Wolowacz, RTI Health Solutions
Brittany Carson, PhD, MHEcon, BSc
Sang Kyu Cho, PharmD, MPH
Haitham Tuffaha, MSc, MBA, RPh, PhD, BSc
Abeer Al Rabayah, MSc, MBA, BSc
Dem Aliaj, MSc
Min-Hua Jen, PhD
Sabina Nduaguba, MSc
Shilpi Swami, MA
Sorrel Wolowacz, PhD
Lixia Yao, PhD
Questions or ideas? Please send an email to Oncologysig@ISPOR.org